Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752998 · ClinicalTrials.gov registry record · NA
Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01752998: Completed NA study, sponsored by Butler Hospital.
NCT01752998 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01752998, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Individuals will be recruited by posted advertisements in the waiting rooms of the PCP offices and by physician referral. After an initial phone screen, research staff will meet with interested individuals in their PCP offices for informed consent, baseline interview and randomization. Participants will be randomized into a Health Education study arm, and receive 7 individual sessions on general health education, or an Intervention study arm, and receive 7 individual sessions of the Treating Opioid Patients' Pain and Sadness (TOPPS) intervention.
Primary Outcome
Pain, as measured by self-report
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Treating Opioid Patients' Pain and Sadness (TOPPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-09 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT01752998 record still lists
NCT01752998 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Health Education is the first listed.
NCT01752998 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01752998 about?
NCT01752998 is a clinical study titled "Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings". Individuals will be recruited by posted advertisements in the waiting rooms of the PCP offices and by physician referral. After an initial phone screen, research staff will meet with interested individuals in their PCP offices for informed consent, baseline interview and randomization. Participants ...
What is the current status of trial NCT01752998?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-09. Estimated completion is 2017-08.
What interventions are being tested in trial NCT01752998?
The interventions under investigation include: Health Education (BEHAVIORAL), Treating Opioid Patients' Pain and Sadness (TOPPS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01752998?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01752998's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia